🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

7 recruiting trials

for Severe Hypoglycemia

The Real-World Control-IQ Glycemic Control and Quality of Life Study in Type 1 Diabetes in France NCT07211126n/a25 sites📍 Agen📍 Angers📍 Bron Tandem Diabetes Care, Inc. · Tests: t:slim X2 insulin pump with Control-IQ technology (Control-IQ System) Precision Subclassification of Mental Health in Diabetes: Digital Twins for Precision Mental Health to Track Subgroups NCT07212075n/a3 sites📍 Bad Mergentheim📍 Bad Mergentheim📍 Würzburg Forschungsinstitut der Diabetes Akademie Mergentheim A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus NCT06575426Phase 1, Phase 21 site📍 Chicago Otsuka Pharmaceutical Factory, Inc. · Tests: OPF-310 Pilot Study Evaluating Safety of ExOlin® in Patients With Poorly Controlled Type 1 Diabetes NCT05221359NA1 site📍 Strasbourg Defymed · Tests: ExOlin®, Insulin aspart Longitudinal Study of the GLUcagon REsponse to Hypoglycemia in Children and Adolescents With New-onset Type 1 DIAbetes NCT06770621NA1 site📍 Brussels Cliniques universitaires Saint-Luc- Université Catholique d… · Tests: Insulin-induced hypoglycemia test, Glucagon profile, Biological sample once, Observation-questionnaire A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes NCT04786262Phase 329 sites📍 Duarte📍 San Francisco📍 Miami Vertex Pharmaceuticals Incorporated · Tests: VX-880, VX-017 A Safety, Tolerability, and Efficacy Study of E-islet 01 in Participants With Type 1 Diabetes NCT07126873Phase 1, Phase 21 site📍 Shanghai EndoCell Therapeutics, Inc. · Tests: Allogeneic Human E-islet (E-islet 01)
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy